Glassman M, George D, Grill B. Gastroesophageal reflux in children. Clinical manifestations, diagnosis, and therapy. Gastroenterol Clin North Am. 1995;24(1):71-98.
2.
Hart JJ. Pediatric gastroesophageal reflux. Am Fam Physician. 1996;54(8):2463-2472.
3.
Romero Y, Cameron AJ, Schaid DJ, et al.Barrett's esophagus: prevalence in symptomatic relatives. Am J Gastroenterol. 2002;97(5):1127-1132.
4.
Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340(11):825-831.
5.
Kawahara H, Dent J, Davidson G. Mechanisms responsible for gastroesophageal reflux in children. Gastroenterology. 1997;113(2):399-408.
6.
Davidson GP, Omari TI. Pathophysiological mechanisms of gastroesophageal reflux disease in children. Curr Gastroenterol Rep. 2001;3(3):257-262.
7.
Vandenplas Y, Hassall E. Mechanisms of gastroesophageal reflux and gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr. 2002;35(2):119-136.
8.
Omari TI, Miki K, Fraser R, et al.Esophageal body and lower esophageal sphincter function in healthy premature infants. Gastroenterology. 1995;109(6):1757-1764.
9.
Trudgill N. Familial factors in the etiology of gastroesophageal reflux disease, Barrett's esophagus, and esophageal adenocarcinoma. Chest Surg Clin North Am. 2002;12(1):15-24.
10.
Cameron AJ, Lagergren J, Henriksson C, et al.Gastroesophageal reflux disease in monozygotic and dizygotic twins. Gastroenterology. 2002;122(1):55-59.
11.
Hu FZ, Preston RA, Post JC, et al.Mapping of a gene for severe pediatric gastroesophageal reflux to chromosome 13q14. JAMA. 2000;284(3):325-334.
12.
Orenstein SR, Shalaby TM, Finch R, et al.Autosomal dominant infantile gastroesophageal reflux disease: exclusion of a 13q14 locus in five well-characterized families. Am J Gastroenterol. 2002;97(11):2725-2732.
13.
Eisen G. The epidemiology of gastroesophageal reflux disease: what we know and what we need to know. Am J Gastroenterol. 2001;96(Suppl 8):S16-S18.
14.
Nelson SP, Chen EH, Syniar GM, Christoffel KK. Prevalence of symptoms of gastroesophageal reflux during infancy. A pediatric practice-based survey. Pediatric Practice Research Group. Arch Pediatr Adolesc Med. 1997;151(6):569-572.
15.
Nelson SP, Chen EH, Syniar GM, Christoffel KK. Prevalence of symptoms of gastroesophageal reflux during childhood: a pediatric practice-based survey. Pediatric Practice Research Group. Arch Pediatr Adolesc Med. 2000;154(2):150-154.
16.
Nelson SP, Chen EH, Syniar GM, Christoffel KK. One-year follow-up of symptoms of gastroesophageal reflux during infancy. Pediatric Practice Research Group. Pediatrics. 1998;102 (6):E67.
17.
El-Serag HB, Bailey NR, Gilger M, Rabeneck L. Endoscopic manifestations of gastroesophageal reflux disease in patients between 18 months and 25 years without neurological deficits. Am J Gastroenterol. 2002;97(7):1635-1639.
18.
Beddow EC, Wilcox DT, Drake DP, et al.Surveillance of Barrett's esophagus in children. J Pediatr Surg. 1999;34(1):88-90; discussion 91.
19.
Waring JP, Feiler MJ, Hunter JG, et al.Childhood gastroesophageal reflux symptoms in adult patients. J Pediatr Gastroenterol Nutr. 2002;35(3):334-338.
20.
Feranchak AP, Orenstein SR, Cohn JF. Behaviors associated with onset of gastroesophageal reflux episodes in infants. Prospective study using split-screen video and pH probe. Clin Pediatr (Phila). 1994;33(11):654-662.
21.
Gunasekaran TS, Hassall EG. Efficacy and safety of omeprazole for severe gastroesophageal reflux in children. J Pediatr. 1993;123(1):148-154.
Ofman JJ, Gralnek IM, Udani J, et al.The cost-effectiveness of the omeprazole test in patients with noncardiac chest pain. Am J Med. 1999;107(3):219-227.
24.
Rudolph CD, Mazur LJ, Liptak GS, et al.Guidelines for evaluation and treatment of gastroesophageal reflux in infants and children: recommendations of the North American Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr. 2001;32(Suppl 2):S1-S31.
25.
Chadwick LM, Kurinczuk JJ, Hallam LA, et al.Clinical and endoscopic predictors of histological oesophagitis in infants. J Paediatr Child Health. 1997;33(5):388-393.
26.
Hassall E. Macroscopic versus microscopic diagnosis of reflux esophagitis: erosions or eosinophils? J Pediatr Gastroenterol Nutr. 1996;22(3):321-325.
27.
Vandenplas Y, Franckx-Goossens A, Pipeleers-Marichal M, et al.Area under pH 4: advantages of a new parameter in the interpretation of esophageal pH monitoring data in infants. J Pediatr Gastroenterol Nutr. 1989;9(1):34-39.
28.
Friesen CA, Hayes R, Hodge C, Roberts CC. Comparison of methods of assessing 24-hour intraesophageal pH recordings in children. J Pediatr Gastroenterol Nutr. 1992;14:252-255.
29.
Weusten BL, Akkermans LM, vanBerge-Henegouwen GP, Smout AJ. Symptom perception in gastroesophageal reflux disease is dependent on spatiotemporal reflux characteristics. Gastroenterology. 1995;108(6):1739-1744.
30.
Vandenplas Y, Belli D. Esophageal pH monitoring. J Pediatr Gastroenterol Nutr. 1996;23(3):337-338.
31.
Wenzl TG. Investigating esophageal reflux with the intraluminal impedance technique. J Pediatr Gastroenterol Nutr. 2002;34(3):261-268.
32.
Wenzl TG, Moroder C, Trachterna M, et al.Esophageal pH monitoring and impedance measurement: a comparison of two diagnostic tests for gastroesophageal reflux. J Pediatr Gastroenterol Nutr. 2002;34(5):519-523.
33.
Loehrl TA, Smith TL. Inflammatory and granulomatous lesions of the larynx and pharynx. Am J Med. 2001;111 (Suppl 8A):113S-117S.
34.
Carroll AE, Garrison MM, Christakis DA. A systematic review of nonpharmacological and nonsurgical therapies for gastroesophageal reflux in infants. Arch Pediatr Adolesc Med. 2002;156(2):109-113.
35.
Orenstein SR, Magill HL, Brooks P. Thickening of infant feedings for therapy of gastroesophageal reflux. J Pediatr. 1987;110(2):181-186.
36.
Salvia G, De Vizia B, Manguso F, et al.Effect of intragastric volume and osmolality on mechanisms of gastroesophageal reflux in children with gastroesophageal reflux disease. Am J Gastroenterol. 2001;96(6):1725-1732.
Nord KS. Peptic ulcer disease in the pediatric population. Pediatr Clin North Am. 1988;35(1):117-140.
39.
Shamburek RD, Schubert ML. Control of gastric acid secretion. Histamine H2-receptor antagonists and H+K(+)-ATPase inhibitors. Gastroenterol Clin North Am. 1992;21(3):527-550.
40.
Sterling CE, Schaffer S, Jolley SG. Home management related to medical treatment for childhood gastroesophageal reflux. Pediatr Nurs. 1993;19(2):167-173.
41.
Wolfe MM, Sachs G. Acid suppression: optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome. Gastroenterology. 2000;118(2 Suppl 1):S9-S31.
42.
Hassall E, Israel D, Shepherd R, et al.Omeprazole for treatment of chronic erosive esophagitis in children: a multicenter study of efficacy, safety, tolerability and dose requirements. International Pediatric Omeprazole Study Group. J Pediatr. 2000;137(6):800-807.
43.
Fonkalsrud EW, Ashcraft KW, Coran AG, et al.Surgical treatment of gastroesophageal reflux in children: a combined hospital study of 7,467 patients. Pediatrics. 1998;101(3 Pt 1):419-422.
44.
Orenstein SR, Di Lorenzo C. Postfundoplication complications in children. Curr Treat Options Gastroenterol. 2001;4(5):441-449.
45.
Di Lorenzo C, Orenstein S. Fundoplication: friend or foe? J Pediatr Gastroenterol Nutr. 2002;34(2):117-124.